EU Microbiome
Regulatory Science Center
Applying regulatory science for new therapies and diagnostics
The PRI is the European Microbiome Regulatory Science Expertise Center, created in 2010 to support the development and registration of therapeutic and diagnostic products emerging from microbiome science.
We work to educate and contribute to the conditions of success for future medicinal innovations emerging from microbiome science, and our ultimate objective is to see these therapeutic innovations achieve EU marketing authorization, thereby giving European patients access to registered microbiome-based medicinal products or validated diagnostics.
Microbiome-based medicinal products
Complex technologies with ecosystemic effects
The future of human and veterinary medicine has been forever changed by the fundamental disruption of microbiome science – we are only now understanding ‘health’ as an ultimate result of a complex interaction between host and one’s microbiome.
The EU Regulatory Framework & Landscape
As for any other medicinal products, microbiome-based medicinal products must comply with the pharmaceutical standards for quality, safety and efficacy and will require a medicinal product marketing authorization to reach market.
The system for regulating medicines in Europe is unique. It is based on a closely coordinated regulatory network of national competent authorities in the Member States of the European Economic Area (EEA), working together with the European Medicines Agency (EMA) and the European Commission.
Overall, most microbiome-based medicinal products are moving through the development process based on interactions between developers and regulators at the national level in a select few of EU member states.
Microbiome Regulatory Science News & Events
2023 PRI Member Event – Ghent, Belgium
All PRI Members are invited to attend the annual Member Event - 7 November 2023. The Pharmabiotic Research Institute (PRI) is hosting its annual General Assembly & Member Event on 7 November 2023, in Ghent (Belgium). This Members-only meeting is our organization's...
ISAPP invites PRI to discuss regulatory science & probiotics
Last week PRI Executive Director Magali Cordaillat-Simmons (PhD) was an invited expert at ISAPP's annual meeting organized in Denver, Colorado. The International Scientific Association for Probiotics and Prebiotics (ISAPP) is "the international non-profit organization...
Microbiome Biomarker Delphi Survey 2nd Round Open (deadline June 6th)
The Delphi Survey on finding a consensus around the development and validation of microbiome-based biomarkers has launched its second round (of two). This second and final round will remain open until the end of the day on June 6th. The second round of the Delphi...
